Clinical application of massively parallel sequencing‐based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11 105 pregnancies with mixed risk factors
Prenatal Diagnosis2012Vol. 32(13), pp. 1225–1232
Citations Over TimeTop 1% of 2012 papers
Dan Shan, Wei Wang, Jinghui Ren, Yali Li, Hua Hu, Zhengfeng Xu, Tze Kin Lau, Jianhong Xie, Weihua Zhao, Hefeng Huang, Jiansheng Xie, Luming Sun, Xiaohong Zhang, Xiaohong Zhang, Weipeng Wang, Shixiu Liao, Rong Qiang, Jiangxia Cao, Qiufang Zhang, Yulin Zhou, Haiyan Zhu, Mei Zhong, Yi Guo, Linhua Lin, Zhiying Gao, Hong Yao, Hong‐Yun Zhang, Lijian Zhao, Fuman Jiang, Fang Chen, Hui Jiang, Songgang Li, Yingrui Li, Jun Wang, Jian Wang, Tao Duan, Yue Su, Xiuqing Zhang, Xiuqing Zhang
Abstract
Our large-scale multicenter study proved that the MPS-based test is of high sensitivity and specificity in detecting fetal trisomies 21 and 18. The introduction of this screening test into a routine clinical setting could avoid about 98% of invasive prenatal diagnostic procedures.
Related Papers
- → Association between cell-free DNA fetal fraction and pregnant character: a retrospective cohort study of 27,793 maternal plasmas(2023)9 cited
- → Expanding the Scope of Noninvasive Prenatal Testing(2015)2 cited
- → Estimates for the sensitivity and false‐positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross‐identification and double‐positive results(2001)3 cited
- → Cell-Free DNA Testing(2016)
- Analysis of prenatal sonography in screening Down syndrome and trisomy 18(2004)